"The
Report The Market for Stem Cell Biobanking and Storage - Size,
Segments, and Trends provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
The purpose of this global
strategic report is to prepare executives, company management, and
industry investors with the data and knowledge necessary to make
informed, educated decisions about commercial opportunities within
the stem cell biobanking market.
This global strategic report
is produced for:
- Executives of Industrial-Scale Biobanks
- Management of Stem Cell Product Companies
- Management of Stem Cell Therapy Companies
- Biobanking Industry Investors
It is designed to increase
your efficiency and effectiveness in:
- Effectively pricing stem cell biobanking services
- Increasing revenue from stem cell biobanking services
- Identifying new or adjunct stem cell biobanking services to offer
- Identifying current market leaders within the stem cell biobanking market
- Characterizing the competitive environment for the stem cell biobanking market
- Identifying threats and opportunities within the stem cell biobanking market
- Acquiring greater market within the stem cell biobanking market
- Making intelligent investment decisions within the stem cell biobanking market
View Report At
:http://www.marketresearchreports.biz/analysis/288623
OVERVIEW
Stem cells are primitive cells
found in all multi-cellular organisms that are characterized by
self-renewal and the capacity to differentiate into mature cell
types. Stem cells are still a relatively new discovery, as the first
mouse embryonic stem cells were derived from embryos in 1981, but it
was not until 1995 that the first culturing of embryonic stem cells
from non-human primates occurred. Induced pluripotent stem cells were
not produced until 2006. As a result of these discoveries, stem cells
can now be derived at various points during the life cycles.
The following are stages
during which stem cells can be derived:
- Embryonic stem cells, derived from blastocysts
- Fetal stem cells, obtained from fetuses
- Post-natal stem cells derived from newborn tissues, including cord blood stem cells from umbilical tissue
- Adult stem cells found in adult tissues, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells
- Induced pluripotent stem cells, reprogrammed from adult cells
- Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
And more
Forces Driving the Stem Cell
Biobanking Market
Stem cell research and
experimentation is largely driven by the unique ability of stem cells
to divide and replicate repeatedly. In addition, their
“unspecialized” nature allows them to differentiate into a wide
variety of specialized cell types. In a developing embryo, stem cells
can differentiate into all of the specialized embryonic tissues. In
adult organisms, stem and progenitor cells act as a repair system for
the body, replenishing specialized cells.
Therefore, the possibilities
arising from these characteristics have resulted in great commercial
interest, with potential applications ranging from the use of stem
cells in reversal and treatment of disease, to targeted cell therapy,
tissue regeneration, pharmacological testing on cell-specific
tissues, and more. Huntington’s disease, Parkinson’s disease, and
spinal cord injuries are examples of conditions for which clinical
applications involving stem cells could offer benefits in halting or
even reversing adverse effects.
However, to have stem cells
easily accessible for research purposes and clinical applications
requires them to be preserved in stable, temperature controlled
conditions. For this reason, a substantial market has evolved for the
biobanking of tissues containing stem cell populations and the
storage of stem cells themselves.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/288623
Stem Cell Biobanking Market
Stem cell biobanking is the
cryogenic storage of stem cells, or biological samples containing
stem cells, for later use. The market for these services is known as
the “Stem Cell Biobanking Market.” Because stem cell biobanking
often involves the long-term storage of stem cell samples, the market
is sometimes is also known as the “Stem Cell Storage Market.” For
purposes of this analysis, these two terms are considered to be
synonymous. A definition of this market is provided below. Stem Cell
Biobanking Market: The stem cell biobanking market is defined as the
total annual revenue derived from the storage of:
- Stem cell lines and their derivatives
- All biological samples that were collected specifically because they contain stem cell populations (e.g. cord blood, adipose tissue, and more)
This report aims to understand
and characterize the competitive environment for the stem cell
biobanking market. As such, the research is focused on identifying
leading participants in the stem cell storage market, distinguishing
their business model, and exploring their relative market share.
Currently, the four leading
providers of biobanking services are: Fisher Bioservices, Biostorage
Technologies, EPL Archives, and Precision Bioservices. All four
companies store millions of biological samples (15 million by
Precision Bioservices, up to 170 million by Fisher Bioservices) and
provide a diverse set of biobanking services. All but Precision
Biosciences are multi-national companies with both U.S. and European
operations. Because each company has large market share within the
stem cell biobanking market, they are explored in detail within this
report.
However, there are also
companies specializing exclusively in stem cell storage. In one
landmark event, Cellular Dynamics International (CDI) and the Coriell
Institute for Medical Research announced receiving multi-million
dollar grants from the California Institute for Regenerative Medicine
(CIRM) for the creation of induced pluripotent stem cell (iPSC) lines
from 3,000 healthy and diseased donors. CIRM awarded CDI $16 million
to create three iPSC lines for each of 3,000 healthy and diseased
donors and awarded the Coriell Institute $10 million to set up and
biobank the iPSC lines. The result will be thecreation of the world’s
largest human iPSC bank, an incredible feat.
This iPSC biobank is one
example of the expanding market for stem cell biobanking services.
Because the goal of stem cell biobanking is to create a repository of
stem cell specimens – including source tissue from which stem cells
can be derived, differentiated cell types produced, and
disease-specific cell lines created – large-scale stem cell
biobanks provide researchers with the opportunity to investigate a
diverse range of conditions using stem cells derived from both
healthy and diseased donors. Importantly, biobanks can greatly expand
the capacity for global research and collaboration.
Key report findings include:
- Current Size of the Stem Cell Biobanking Market
- Trailing 5-Year Market Size Data (2011-2015)
- 5-year Market Size Projections (2016-2020)
- Market Segmentation
- Market Share by Segment
- Key Industry Leaders
- Detailed Competitive Environment Analysis
- Analysis of Stem Cell Storage Applications (End-Uses)
- Number of Stem Cell Samples Banked, by Industry Leader
- Identification of Opportunities within the Stem Cell Biobanking Market
- And Much More
Competing within the stem cell
biobanking market can involve complicated and confusing decisions,
but it doesn’t need to. Claim this global strategic report to
quickly understand current and future trends within the stem cell
biobanking marketplace, identify opportunities by market segment, and
derive more revenue from your stem cell biobanking products and
services.
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment